DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain division on March 16, 2015, with a contract ceiling value of $5.0 million and an ultimate completion date of November 12, 2025. The contract, designated TRICARE NORTH, operates under a firm fixed-price delivery order structure with no set-aside provisions, positioning DMS Pharmaceutical Group as a critical pharmaceutical supplier for Department of Defense healthcare operations. The funding source is the Defense Logistics Agency Medical Supply Chain, a defense agency function responsible for managing pharmaceutical inventory and distribution to military treatment facilities.
The contract scope encompasses a comprehensive range of pharmaceutical products and medical consumables, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The product portfolio spans multiple therapeutic categories, including oncology treatments, immunosuppressants, biologic agents, emergency medications such as epinephrine auto-injectors and naloxone, specialty surgical products, contraceptive devices, vaccines, antibiotics, antivirals, pain management drugs, and routine pharmaceuticals. Delivery orders have been issued for quantities ranging from under $100 to over $115,000, with the majority awarded without set-aside designations, demonstrating the contractor's competitive capability in unrestricted federal procurement. This indefinite delivery vehicle enables the Defense Logistics Agency to issue firm fixed-price orders on an as-needed basis to fulfill recurring and specialized pharmaceutical supply requirements across the military healthcare system.
Generated 3/4/26, 5:50 PM